ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $14,542,000 | +388.2% | 84,499 | +256.0% | 0.00% | – |
| Q2 2021 | $2,979,000 | -84.6% | 23,735 | -83.4% | 0.00% | -100.0% |
| Q1 2021 | $19,349,000 | -64.2% | 142,678 | -66.2% | 0.01% | -61.5% |
| Q4 2020 | $54,060,000 | +949.5% | 422,536 | +822.9% | 0.01% | +1200.0% |
| Q3 2020 | $5,151,000 | -76.7% | 45,784 | -80.3% | 0.00% | -87.5% |
| Q2 2020 | $22,140,000 | +130.1% | 232,383 | +117.1% | 0.01% | +100.0% |
| Q1 2020 | $9,621,000 | -74.6% | 107,064 | -85.0% | 0.00% | -75.0% |
| Q4 2019 | $37,887,000 | +19.0% | 714,583 | -11.3% | 0.02% | +6.7% |
| Q3 2019 | $31,829,000 | +114.7% | 805,573 | +123.2% | 0.02% | +114.3% |
| Q2 2019 | $14,828,000 | +79.5% | 360,954 | +103.4% | 0.01% | +75.0% |
| Q1 2019 | $8,263,000 | +632.5% | 177,443 | +585.1% | 0.00% | – |
| Q4 2018 | $1,128,000 | -79.0% | 25,900 | -72.4% | 0.00% | -100.0% |
| Q3 2018 | $5,370,000 | -77.1% | 93,830 | -80.6% | 0.00% | -83.3% |
| Q2 2018 | $23,457,000 | +232.0% | 483,459 | +167.5% | 0.01% | +300.0% |
| Q1 2018 | $7,066,000 | +96.3% | 180,715 | +113.1% | 0.00% | +50.0% |
| Q4 2017 | $3,599,000 | -61.6% | 84,819 | -66.2% | 0.00% | -71.4% |
| Q3 2017 | $9,379,000 | +312.8% | 251,312 | +236.2% | 0.01% | +600.0% |
| Q2 2017 | $2,272,000 | -52.2% | 74,749 | -58.4% | 0.00% | -75.0% |
| Q1 2017 | $4,755,000 | -1.2% | 179,671 | -4.8% | 0.00% | -20.0% |
| Q4 2016 | $4,815,000 | -59.0% | 188,678 | -41.8% | 0.01% | -54.5% |
| Q3 2016 | $11,736,000 | +103.6% | 324,273 | +91.2% | 0.01% | +83.3% |
| Q2 2016 | $5,764,000 | +2417.0% | 169,640 | +1858.2% | 0.01% | – |
| Q1 2016 | $229,000 | -97.9% | 8,663 | -96.1% | 0.00% | -100.0% |
| Q4 2015 | $10,810,000 | +38.6% | 221,702 | -29.2% | 0.01% | +71.4% |
| Q3 2015 | $7,801,000 | -36.4% | 313,315 | -19.1% | 0.01% | -36.4% |
| Q2 2015 | $12,259,000 | -33.5% | 387,438 | -20.0% | 0.01% | -35.3% |
| Q1 2015 | $18,440,000 | +20.5% | 484,500 | +23.4% | 0.02% | +13.3% |
| Q4 2014 | $15,298,000 | +46.5% | 392,668 | +13.7% | 0.02% | +36.4% |
| Q3 2014 | $10,445,000 | +5148.7% | 345,411 | +5783.3% | 0.01% | – |
| Q2 2014 | $199,000 | – | 5,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 1,480,060 | $53,563,000 | 85.86% |
| NEXTHERA CAPITAL LP | 217,817 | $7,883,000 | 4.84% |
| Novo Holdings A/S | 903,833 | $32,710,000 | 2.90% |
| SECTORAL ASSET MANAGEMENT INC | 481,765 | $17,435,000 | 1.71% |
| Perceptive Advisors | 589,890 | $21,348,000 | 1.38% |
| RA Capital Management | 318,565 | $11,529,000 | 1.19% |
| OAK RIDGE INVESTMENTS LLC | 1,226,468 | $44,386,000 | 1.15% |
| Granahan Investment Management | 817,149 | $29,573,000 | 0.97% |
| Eventide Asset Management | 428,900 | $15,522,000 | 0.95% |
| QVT Financial LP | 636,764 | $23,044,000 | 0.87% |